Colorectal Lymphoma: A Review

Abstract

Non-Hodgkin lymphoma (NHL) that primarily involves the colon is rare and should be distinguished from the more common systemic nodal lymphoma. It has unique clinical expectations and management consideration. Different histologic subtypes of NHL involve the colon, which varies in the clinical behavior and likelihood of obtaining durable remissions with treatment. This article will review the current understanding of the different histologic subtypes of primary colorectal lymphoma and propose management algorithms.

Keywords

primary colorectal lymphoma - extranodal - gastrointestinal - large bowel

• References

• 1 Swerdlow SH, Campo E, Pileri SA. , et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127 (20) 2375-2390
• 2 Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003; 14 (01) 131-139
• 3 Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980; 46 (01) 215-222
• 4 d'Amore F, Brincker H, Grønbaek K. , et al; Danish Lymphoma Study Group. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. J Clin Oncol 1994; 12 (08) 1673-1684
• 5 Blackledge G, Bush H, Dodge OG, Crowther D. A study of gastro-intestinal lymphoma. Clin Oncol 1979; 5 (03) 209-219
• 6 Contreary K, Nance FC, Becker WF. Primary lymphoma of the gastrointestinal tract. Ann Surg 1980; 191 (05) 593-598
• 7 Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 1978; 42 (02) 693-707
• 8 Dragosics B, Bauer P, Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer 1985; 55 (05) 1060-1073
• 9 Henry CA, Berry RE. Primary lymphoma of the large intestine. Am Surg 1988; 54 (05) 262-266
• 10 Jinnai D, Iwasa Z, Watanuki T. Malignant lymphoma of the large intestine--operative results in Japan. Jpn J Surg 1983; 13 (04) 331-336
• 11 Kashimura A, Murakami T. Malignant lymphoma of large intestine --15-year experience and review of literature. Gastroenterol Jpn 1976; 11 (02) 141-147
• 12 Koch P, del Valle F, Berdel WE. , et al; German Multicenter Study Group. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19 (18) 3861-3873
• 13 Papaxoinis G, Papageorgiou S, Rontogianni D. , et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma 2006; 47 (10) 2140-2146
• 14 Zighelboim J, Larson MV. Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy. J Clin Gastroenterol 1994; 18 (04) 291-297
• 15 Bairey O, Ruchlemer R, Shpilberg O. Non-Hodgkin's lymphomas of the colon. Isr Med Assoc J 2006; 8 (12) 832-835
• 16 Stanojević GZ, Stojanović MP, Stojanović MM. , et al. Non-Hodgkin's lymphomas of the large bowel-clinical characteristics, prognostic factors and survival. Acta Chir Iugosl 2008; 55 (03) 109-114
• 17 Fan CW, Changchien CR, Wang JY. , et al. Primary colorectal lymphoma. Dis Colon Rectum 2000; 43 (09) 1277-1282
• 18 Cho MJ, Ha CS, Allen PK, Fuller LM, Cabanillas F, Cox JD. Primary non-Hodgkin lymphoma of the large bowel. Radiology 1997; 205 (02) 535-539
• 19 Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol 2009; 146 (01) 91-94
• 20 Clarke CA, Morton LM, Lynch C. , et al. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 2013; 109 (01) 280-288
• 21 Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood 2006; 108 (04) 1363-1369
• 22 Brennan P, Scélo G, Hemminki K. , et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005; 93 (01) 159-166
• 23 Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54 (08) 1121-1125
• 24 Frumkin H. Agent Orange and cancer: an overview for clinicians. CA Cancer J Clin 2003; 53 (04) 245-255
• 25 Ulcickas Yood M, Quesenberry Jr CP, Guo D. , et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007; 46 (01) 107-112
• 26 Kaplan LD. HIV-associated lymphoma. Best Pract Res Clin Haematol 2012; 25 (01) 101-117
• 27 Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011; 117 (06) 1792-1798
• 28 Smith MR, Greene WC. Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. J Clin Invest 1991; 87 (03) 761-766
• 29 Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350 (13) 1328-1337
• 30 Ekström Smedby K, Vajdic CM, Falster M. , et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111 (08) 4029-4038
• 31 Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 2011; 47 (16) 2422-2430
• 32 Saadoun D, Sellam J, Ghillani-Dalbin P, Crecel R, Piette JC, Cacoub P. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 2006; 166 (19) 2101-2108
• 33 Shapiro RS. Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologists. Am J Hematol 2011; 86 (01) 48-55
• 34 Larroche C, Cacoub P, Soulier J. , et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 2002; 69 (02) 119-126
• 35 Avilés A, Neri N, Huerta-Guzmán J. Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients. J Surg Oncol 2002; 80 (02) 111-115
• 36 Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961; 49: 80-89
• 37 Glick DD, Soule EH. Primary malignant lymphoma of colon or appendix. Report of 27 cases. Arch Surg 1966; 92 (01) 144-151
• 38 Perry PM, Cross RM, Morson BC. Primary malignant lymphoma of the rectum (22 cases). Proc R Soc Med 1972; 65 (01) 72
• 39 Yu H, Wang Y, Peng L, Lia A, Zhang Y. Endoscopic manifestations of primary colorectal lymphoma. Hepatogastroenterology 2014; 61 (129) 76-78
• 40 Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10 (09) 1023-1033
• 41 Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8 (08) 727-737
• 42 Economopoulos T, Asprou N, Stathakis N. , et al. Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics. Leuk Lymphoma 1996; 21 (1-2): 131-136
• 43 Otter R, Gerrits WB, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25 (08) 1203-1210
• 44 d'Amore F, Christensen BE, Brincker H. , et al; Danish LYFO Study Group. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer 1991; 27 (10) 1201-1208
• 45 Myung SJ, Joo KR, Yang SK. , et al. Clinicopathologic features of ileocolonic malignant lymphoma: analysis according to colonoscopic classification. Gastrointest Endosc 2003; 57 (03) 343-347
• 46 Iwamuro M, Okada H, Takata K. , et al. Colorectal manifestation of follicular lymphoma. Intern Med 2016; 55 (01) 1-8
• 47 Mendelson RM, Fermoyle S. Primary gastrointestinal lymphomas: a radiological-pathological review. Part 1: stomach, oesophagus and colon. Australas Radiol 2005; 49 (05) 353-364
• 48 Ghai S, Pattison J, Ghai S, O'Malley ME, Khalili K, Stephens M. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics 2007; 27 (05) 1371-1388
• 49 Devaney K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin's disease. Am J Clin Pathol 1991; 95 (06) 794-801
• 50 Palli D, Trallori G, Bagnoli S. , et al. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000; 119 (03) 647-653
• 51 Cai S, Cannizzo Jr F, Bullard Dunn KM, Gibbs JF, Czuczman M, Rajput A. The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum. Am J Surg 2007; 193 (03) 409-412 , discussion 412
• 52 Kim YH, Lee JH, Yang SK. , et al. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) Study. Dig Dis Sci 2005; 50 (12) 2243-2247
• 53 Shepherd NA, Hall PA, Coates PJ, Levison DA. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology 1988; 12 (03) 235-252
• 54 Doolabh N, Anthony T, Simmang C. , et al. Primary colonic lymphoma. J Surg Oncol 2000; 74 (04) 257-262
• 55 Hwang WS, Yao JC, Cheng SS, Tseng HH. Primary colorectal lymphoma in Taiwan. Cancer 1992; 70 (03) 575-580
• 56 Son HJ, Rhee PL, Kim JJ. , et al. Primary T-cell lymphoma of the colon. Korean J Intern Med 1997; 12 (02) 238-241
• 57 Lee HJ, Han JK, Kim TK, Kim YH, Kim KW, Choi BI. Peripheral T-cell lymphoma of the colon: double-contrast barium enema examination findings in six patients. Radiology 2001; 218 (03) 751-756
• 58 Wang MH, Wong JM, Lien HC, Lin CW, Wang CY. Colonoscopic manifestations of primary colorectal lymphoma. Endoscopy 2001; 33 (07) 605-609
• 59 Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977; 61 (06) 1023-1027
• 60 Moormeier JA, Williams SF, Golomb HM. The staging of non-Hodgkin's lymphomas. Semin Oncol 1990; 17 (01) 43-50
• 61 Ruskoné-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon A, De Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut 2003; 52 (06) 912-913
• 62 Dana BW, Dahlberg S, Nathwani BN. , et al. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 1993; 11 (04) 644-651
• 63 Vaidya R, Habermann TM, Donohue JH. , et al. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol 2013; 24 (09) 2439-2443
• 64 Kim SJ, Kang HJ, Kim JS. , et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood 2011; 117 (06) 1958-1965
• 65 Lee J, Kim WS, Kim K. , et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res 2007; 31 (03) 359-364
• 66 Phan J, Mazloom A, Medeiros LJ. , et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 2010; 28 (27) 4170-4176
• 67 Hong J, Kim AJ, Park JS. , et al. Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis. Korean J Hematol 2010; 45 (04) 253-259
• 68 Persky DO, Unger JM, Spier CM. , et al; Southwest Oncology Group. Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol 2008; 26 (14) 2258-2263
• 69 Reyes F, Lepage E, Ganem G. , et al; Groupe d'Etude des Lymphomes de l'Adulte (GELA). ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005; 352 (12) 1197-1205
• 70 Bellesi G, Alterini R, Messori A. , et al. Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas. Br J Cancer 1989; 60 (02) 244-248
• 71 Koh PK, Horsman JM, Radstone CR, Hancock H, Goepel JR, Hancock BW. Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998). Int J Oncol 2001; 18 (04) 743-748
• 72 Pfreundschuh M, Trümper L, Osterborg A. , et al; MabThera International Trial Group. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7 (05) 379-391
• 73 Guadagnolo BA, Li S, Neuberg D. , et al. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006; 64 (03) 928-934
• 74 Seymour JF, Pro B, Fuller LM. , et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. J Clin Oncol 2003; 21 (11) 2115-2122
• 75 Shia J, Teruya-Feldstein J, Pan D. , et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol 2002; 26 (02) 216-224
• 76 Leitch HA, Gascoyne RD, Chhanabhai M, Voss NJ, Klasa R, Connors JM. Limited-stage mantle-cell lymphoma. Ann Oncol 2003; 14 (10) 1555-1561
• 77 Gill BS, Vargo JA, Pai SS, Balasubramani GK, Beriwal S. Management trends and outcomes for stage I to II mantle cell lymphoma using the National Cancer Data Base: ascertaining the ideal treatment paradigm. Int J Radiat Oncol Biol Phys 2015; 93 (03) 668-676
• 78 Takenaka R, Tomoda J, Sakata T. , et al. Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol 2000; 15 (03) 331-335
• 79 Tsang RW, Gospodarowicz MK, Pintilie M. , et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 2001; 50 (05) 1258-1264
• 80 Kobayashi T, Takahashi N, Hagiwara Y. , et al. Successful radiotherapy in a patient with primary rectal mucosa-associated lymphoid tissue lymphoma without the API2-MALT1 fusion gene: a case report and review of the literature. Leuk Res 2008; 32 (01) 173-175
• 81 Kiesewetter B, Raderer M. Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. Blood 2013; 122 (08) 1350-1357
• 82 Akasaka R, Chiba T, Dutta AK. , et al. Colonic mucosa-associated lymphoid tissue lymphoma. Case Rep Gastroenterol 2012; 6 (02) 569-575
• 83 Tanaka S, Ohta T, Kaji E, Kosaka T, Murakami I. EMR of mucosa-associated lymphoid tissue lymphoma of the rectum. Gastrointest Endosc 2003; 57 (07) 956-959
• 84 Orita M, Yamashita K, Okino M. , et al. A case of MALT (mucosa-associated lymphoid tissue) lymphoma occurring in the rectum. Hepatogastroenterology 1999; 46 (28) 2352-2354
• 85 Okamura T, Suga T, Iwaya Y. , et al. Helicobacter pylori-negative primary rectal MALT lymphoma: complete remission after radiotherapy. Case Rep Gastroenterol 2012; 6 (02) 319-327
• 86 Kiesewetter B, Ferreri AJ, Raderer M. Chemoimmunotherapy for mucosa-associated lymphoid tissue-type lymphoma: a review of the literature. Oncologist 2015; 20 (08) 915-925